Form 4: Plexus CFO Sells Shares Under 10b5-1 Plan

Plexus Corp.'s Executive VP and CFO, Patrick John Jermain, sold 3,587 shares of common stock for $204.09 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Patrick John Jermain, Executive VP & CFO of Plexus Corp. (PLXS), reported a sale of common stock.
• The transaction involved the disposition of 3,587 shares of Plexus Corp. common stock.
• The shares were sold at a price of $204.09 per share.
• The sale was executed on February 4, 2026.
• Following this transaction, Jermain directly beneficially owns 16,882 shares of common stock.
• Additionally, 3,719 shares are held indirectly in the Plexus Corp. 401(k) Retirement Plan as of the last report from the Plan's trustee.
• The transaction was made pursuant to a Rule 10b5-1 trading plan, indicating a pre-scheduled sale.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While insider selling can sometimes be perceived negatively, the execution under a Rule 10b5-1 plan suggests a pre-planned transaction for personal financial management rather than a reaction to new company-specific information.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction rather than a discretionary sale based on new material non-public information.

Negatives

• An Executive VP and CFO sold a notable number of shares, which could be interpreted by some as a lack of confidence, although mitigated by the 10b5-1 plan.

Risks

• NA

Future Outlook

NA

Management Comments

• NA

Industry Context

StockSavvy.ai notes that insider sales, particularly those executed under Rule 10b5-1 plans, are a routine occurrence in the market. These plans allow executives to sell shares over a predetermined period to avoid accusations of trading on material non-public information, often for personal financial planning or diversification, and do not necessarily signal a negative outlook for the company or its industry peers.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders: May interpret the sale differently; some might view it as a minor negative, while others will see it as a routine, pre-planned transaction.

Next Steps

• NA

Key Dates

Recommendation

The sale by the Executive VP and CFO was conducted under a Rule 10b5-1 plan, indicating a pre-scheduled transaction for personal financial management rather than a discretionary sale based on new material information. This type of insider transaction is generally considered routine and does not provide sufficient new information to alter an investment recommendation for Plexus Corp. at this time.

Keywords

Plexus Corp, PLXS, insider trading, Form 4, stock sale, executive compensation, 10b5-1 plan, Patrick John Jermain, CFO